Written in Blood: DNA Analyses for Improved Cancer Management
Thursday, March 10, 2016
9AM to 1:30PM
Kiewit Auditorium, University of Arizona Cancer Center
Rita R. Colwell, PhD
Distinguished University Professor, University of Maryland at College Park
Distinguished University Professor, Johns Hopkins University Bloomberg School of Public Health
Senior Advisor and Chairman Emeritus, Canon US Life Sciences, Inc.
President and CEO of CosmosID, Inc.
11th Director of the National Science Foundation, 1998-2004
"Next Generation Sequencing Based Diagnostics: Climate, Oceans, and the Clinic"
Confirmed Speakers, Topic Titles to follow
Taylor J. Jensen, PhD, Director of Research and Development, Sequenom Inc., San Diego, CA
"Comprehensive tumor profiling in the plasma of patients with non-hematological malignancies"
Ali McBride, PharmD, MS, BCPS, Clinical Coordinator Hematology/Oncology, UA Cancer Center
Baldour Salhia, PhD, Assistant Professor, Translational Genomics Institute, Integrated Cancer Genomics Division, Phoenix, AZ
"Detecting DNA methylation from liquid biopsies for assessing risk recurrence in breast cancer"
Debrah Thompson, PhD, Director of Research, HTG Molecular Diagnostics, Tucson, AZ
"Measurement of miRNA and mRNA from blood products using HTG EdgeSeq"
George S. Watts, PhD, Research Associate Professor, University of Arizona Cancer Center,
Co-Director, Genomics Shared Resource
"Improving the diagnosis of febrile neutropenia in cancer patients"
Lukas Vrba, PhD, Assistant Research Scientist, Genomics Shared Resource, UA Cancer Center
"In silico discovery of DNA methylation markers for monitoring cancer"